Pfizer files lawsuit against Metsera and its directors & Novo Nordisk in the Delaware Court of Chancery for breach of merger agreement: New York Monday, November 3, 2025, 09:00 Hr ...
Peethaambaran Kunnathoor, Chennai Monday, November 3, 2025, 08:00 Hrs [IST] ...
Centre brings IPC under the jurisdiction of CAT to address service related grievances: Gireesh Babu, New Delhi Monday, November 3, 2025, 08:00 Hrs [IST] The Union ministry of pers ...
IPC develops & introduces quality standards for 22 blood components to ensure safe blood transfusion
IPC develops & introduces quality standards for 22 blood components to ensure safe blood transfusion: Shardul Nautiyal, Mumbai Monday, November 3, 2025, 08:00 Hrs [IST] The Indian ...
CRDMOs transform early drug development with seamless integration of translational & clinical research: Nandita Vijayasimha, Bengaluru Monday, November 3, 2025, 08:00 Hrs [IST] Co ...
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility
ProImmune Ltd, a global leader in life science reagents and services, announced the launch of its new ProVE SL self-loading MHC Class I monomers. The novel reagents for antigen-specific CD8+ T cell ...
Ascletis Pharma Inc announced that it has selected ASC36, a once-monthly, potentially best-in-class subcutaneously administered amylin receptor agonist, as a clinical development candidate. Ascletis ...
Positive results from the global PREVAIL phase III trial showed that gefurulimab met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement from baseline ...
Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, released a new white paper detailing the rapid rise of therapeutic radiopharmaceutical research and the ...
PharmaDrug Inc, a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines, announced that it has executed a definitive securities exchange ...
Novo Nordisk, a leading global healthcare company founded in 1923 and headquartered in Denmark, announced that it has submitted an unsolicited proposal to acquire Metsera, Inc. The acquisition of ...
Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of its new Neurotoxicity Testing Services; expanding its established neuroscience discovery ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback